切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2021, Vol. 10 ›› Issue (03) : 242 -245. doi: 10.3877/cma.j.issn.2095-3232.2021.03.003

所属专题: 文献

专家论坛

肝细胞癌伴胆管癌栓的外科治疗争议与体会
栗玉龙1, 杨新伟1, 郑玉廷1, 徐畅1, 胡明泰1, 谢峰1, 阚彤1, 谭薇锋1, 罗祥基1,(), 姜小清1, 张柏和1   
  1. 1. 200438 上海东方肝胆外科医院胆道三科
  • 收稿日期:2021-03-18 出版日期:2021-06-10
  • 通信作者: 罗祥基
  • 基金资助:
    国家自然科学基金(81902940); 上海市卫生和计划生育委员会课题项目(20164Y0109)

Controversies and experience on surgical treatments for hepatocellular carcinoma with bile duct tumor thrombus

Yulong Li1, Xinwei Yang1, Yuting Zheng1   

  • Received:2021-03-18 Published:2021-06-10
引用本文:

栗玉龙, 杨新伟, 郑玉廷, 徐畅, 胡明泰, 谢峰, 阚彤, 谭薇锋, 罗祥基, 姜小清, 张柏和. 肝细胞癌伴胆管癌栓的外科治疗争议与体会[J]. 中华肝脏外科手术学电子杂志, 2021, 10(03): 242-245.

Yulong Li, Xinwei Yang, Yuting Zheng. Controversies and experience on surgical treatments for hepatocellular carcinoma with bile duct tumor thrombus[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2021, 10(03): 242-245.

[1]
Valery PC, Laversanne M, Clark PJ, et al. Projections of primary liver cancer to 2030 in 30 countries worldwide[J]. Hepatology, 2018, 67(2):600-611.
[2]
Kudo M, Izumi N, Ichida T, et al. Report of the 19th follow-up survey of primary liver cancer in Japan[J]. Hepatol Res, 2016, 46(5):372-390.
[3]
Orimo T, Kamiyama T, Yokoo H, et al. Hepatectomy for hepatocellular carcinoma with bile duct tumor thrombus, including cases with obstructive jaundice[J]. Ann Surg Oncol, 2016, 23(8): 2627-2634.
[4]
Navadgi S, Chang CC, Bartlett A, et al. Systematic review and meta-analysis of outcomes after liver resection in patients with hepatocellular carcinoma (HCC) with and without bile duct thrombus[J]. HPB, 2016, 18(4):312-316.
[5]
Xin KY, Yee LS, Yong TT, et al. Obstructive jaundice due to intraductal tumour thrombus in recurrent hepatocellular carcinoma: what is the optimal therapeutic approach?[J]. Hepatogastroenterology, 2014, 61(135):1863-1866.
[6]
Wong TC, Cheung TT, Chok KS, et al. Outcomes of hepatectomy for hepatocellular carcinoma with bile duct tumour thrombus[J]. HPB, 2015, 17(5):401-408.
[7]
Noda T, Nagano H, Tomimaru Y, et al. Prognosis of hepatocellular carcinoma with biliary tumor thrombi after liver surgery[J]. Surgery, 2011, 149(3):371-377.
[8]
Hu XG, Mao W, Hong SY, et al. Surgical treatment for hepatocellular carcinoma with bile duct invasion[J]. Ann Surg Treat Res, 2016, 90(3):139-146.
[9]
Oba A, Takahashi S, Kato Y, et al. Usefulness of resection for hepatocellular carcinoma with macroscopic bile duct tumor thrombus[J]. Anticancer Res, 2014, 34(8):4367-4372.
[10]
Moon DB, Hwang S, Wang HJ, et al. Surgical outcomes of hepatocellular carcinoma with bile duct tumor thrombus: a Korean multicenter study[J]. World J Surg, 2013, 37(2):443-451.
[11]
Yang X, Qiu Z, Ran R, et al. Prognostic importance of bile duct invasion in surgical resection with curative intent for hepatocellular carcinoma using PSM analysis[J]. Oncol Lett, 2018, 16(3):3593-3602.
[12]
Qin LX, Ma ZC, Wu ZQ, et al. Diagnosis and surgical treatments of hepatocellular carcinoma with tumor thrombosis in bile duct: experience of 34 patients[J]. World J Gastroenterol, 2004, 10(10):1397-1401.
[13]
Ikenaga N, Chijiiwa K, Otani K, et al. Clinicopathologic characteristics of hepatocellular carcinoma with bile duct invasion[J]. J Gastrointest Surg, 2009, 13(3):492-497.
[14]
European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma[J]. J Hepatol, 2012, 56(4):908-943.
[15]
Lee JM, Jang BK, Lee YJ, et al. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis[J]. Clin Mol Hepatol, 2016, 22(1):160-167.
[16]
Lau WY, Leung KL, Leung TW, et al. Obstructive jaundice secondary to hepatocellular carcinoma[J]. Surg Oncol, 1995, 4(6):303-308.
[17]
Yeh CN, Jan YY, Lee WC, et al. Hepatic resection for hepatocellular carcinoma with obstructive jaundice due to biliary tumor thrombi[J]. World J Surg, 2004, 28(5):471-475.
[18]
Satoh S, Ikai I, Honda G, et al. Clinicopathologic evaluation of hepatocellular carcinoma with bile duct thrombi[J]. Surgery, 2000, 128(5):779-783.
[19]
Xiangji L, Weifeng T, Bin Y, et al. Surgery of hepatocellular carcinoma complicated with cancer thrombi in bile duct: efficacy for criteria for different therapy modalities[J]. Langenbecks Arch Surg, 2009, 394(6):1033-1039.
[20]
Fukuda S, Okuda K, Imamura M, et al. Surgical resection combined with chemotherapy for advanced hepatocellular carcinoma with tumor thrombus: report of 19 cases[J]. Surgery, 2002, 131(3):300-310.
[21]
Peng SY, Wang JW, Liu YB, et al. Surgical intervention for obstructive jaundice due to biliary tumor thrombus in hepatocellular carcinoma[J]. World J Surg, 2004, 28(1):43-46.
[22]
Yamamoto S, Hasegawa K, Inoue Y, et al. Bile duct preserving surgery for hepatocellular carcinoma with bile duct tumor thrombus[J]. Ann Surg, 2015, 261(5):e123-125.
[23]
Agarwal AK, Mandal S, Singh S, et al. Biliary obstruction in gallbladder cancer is not sine qua non of inoperability[J]. Ann Surg Oncol, 2007, 14(10):2831-2837.
[24]
Esaki M, Shimada K, Sano T, et al. Surgical results for hepatocellular carcinoma with bile duct invasion: a clinicopathologic comparision between macroscopic and microscopic tumor thrombus[J]. J Surg Oncol, 2005, 90(4):226-232.
[25]
Kasai Y, Hatano E, Seo S, et al. Hepatocellular carcinoma with bile duct tumor thrombus: surgical outcomes and the prognostic impact of concomitant major vascular invasion[J]. World J Surg, 2015, 39(6): 1485-1493.
[26]
Shiomi M, Kamiya J, Nagino M, et al. Hepatocellular carcinoma with biliary tumor thrombi: aggressive operative approach after appropriate preoperative management[J]. Surgery, 2001, 129(6):692-698.
[27]
Luo X, Tan W, Yi B, et al. Surgery of hepatocellular carcinoma complicated with cancer thrombi in bile duct: efficacy for criteria for different therapy modalities[J]. Langenbecks Arch Surg, 2009, 394(6):1033-1039.
[1] 魏淑婕, 惠品晶, 丁亚芳, 张白, 颜燕红, 周鹏, 黄亚波. 单侧颈内动脉闭塞患者行颞浅动脉-大脑中动脉搭桥术的脑血流动力学评估[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1046-1055.
[2] 钱龙, 陆晓峰, 王行舟, 杜峻峰, 沈晓菲, 管文贤. 神经系统调控胃肠道肿瘤免疫应答研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 86-89.
[3] 叶晓琳, 刘云飞, 庞明泉, 王海久, 任利, 侯立朝, 于文昊, 王志鑫, 樊海宁. 肝再生细胞来源及调控机制的研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 96-99.
[4] 尚培中, 张润萍, 张伟, 贾国洪, 李晓武, 苗建军, 刘冰. 梗阻性黄疸临床防治新技术单中心应用研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 104-107.
[5] 彭旭, 邵永孚, 李铎, 邹瑞, 邢贞明. 结肠肝曲癌的诊断和外科治疗[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 108-110.
[6] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[7] 曹迪, 张玉茹. 经腹腔镜生物补片修补直肠癌根治术后盆底疝1例[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 115-116.
[8] 姚宏伟, 魏鹏宇, 高加勒, 张忠涛. 不断提高腹腔镜右半结肠癌D3根治术的规范化[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 1-4.
[9] 杜晓辉, 崔建新. 腹腔镜右半结肠癌D3根治术淋巴结清扫范围与策略[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 5-8.
[10] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[11] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[12] 冯冰, 邹秋果, 梁振波, 卢艳明, 曾奕, 吴淑苗. 老年非特殊型浸润性乳腺癌超声征象与分子生物学指标的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 48-51.
[13] 栗艳松, 冯会敏, 刘明超, 刘泽鹏, 姜秋霞. STIP1在三阴性乳腺癌组织中的表达及临床意义研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 52-56.
[14] 李永胜, 孙家和, 郭书伟, 卢义康, 刘洪洲. 高龄结直肠癌患者根治术后短期并发症及其影响因素[J]. 中华临床医师杂志(电子版), 2023, 17(9): 962-967.
[15] 袁媛, 赵良平, 刘智慧, 张丽萍, 谭丽梅, 閤梦琴. 子宫内膜癌组织中miR-25-3p、PTEN的表达及与病理参数的关系[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1016-1020.
阅读次数
全文


摘要